Events

Rappel de N-85 HANDHELD CAPNOGRAPH/PULSE OXIMETER

Selon Health Canada (via FOI), ce/cet/cette rappel concerne un dispositif en/au/aux/à Canada qui a été fabriqué par COVIDIEN LLC.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    97288
  • Classe de risque de l'événement
    II
  • Date de mise en oeuvre de l'événement
    2011-04-12
  • Pays de l'événement
    Canada
  • Source de l'événement
    HC
  • Notes / Alertes
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notes supplémentaires dans les données
  • Cause
    Oridion medicalthe manufacturer of filterline products has discovered an issue with specific lots of the filterline h set infant/neonatal (part 006324) distributed with nellcor(covidien) n85 monitor kits. the issue concerns the presence of fine plastic strands inside the endo-tracheal tube side of the airway adapter which may become dislodged and inhaled by the patient.

Device

N-85 HANDHELD CAPNOGRAPH/PULSE OXIMETER
  • Modèle / numéro de série
    Model Catalog: N-85 (Lot serial: >THAN 10 PLS CONTACT MFG)
  • Description du dispositif
    FILTERLINE H SET INFANT/NEONATAL IN N-85 MONITOR KIT
  • Manufacturer
    COVIDIEN LLC

Manufacturer

COVIDIEN LLC
  • Adresse du fabricant
    MANSFIELD
  • Société-mère du fabricant (2017)
    Medtronic plc
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    HC